Moreover, when we used TCGA data combined with MIXTURE, an immune tumor microenvironment estimation method based on gene expression data, we validated again that IRF8 expression was associated with a relatively more abundant CD8+ T cell infiltration in ER-negative, HER2+, and TNBC subtypes (Additional file 2: Figure S2). The gene discussed is ESR1; the disease is neoplasm.